BAVENCIO J Code: J9023

Drug & Product Overview

HCPCS Descriptor Injection, avelumab, 10 mg

HCPCS Added Date January 1, 2018

Manufacturer EMD Serono

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection, Solution, Concentrate

About BAVENCIO

Bavencio is a medication aligned to the HCPCS J Code: J9023 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the intravenous route and manufactured by EMD Serono.

According to CMS Drug Use Information: Avelumab is used to treat various types of cancer. It works by changing the action of your own immune system, directing it to attack cancer cells. Avelumab belongs to a class of drugs known as monoclonal antibodies.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
44087-3535-01	Bavencio	EMD Serono, Inc.	20	200 MG / 10 ML

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

BAVENCIO Pricing & Reimbursement

J9023 Private Payer Reimbursement

$107.72 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

BAVENCIO Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 9.74%

Avg. Days to File 5.4days

Avg. Days to Pay 21.9days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9023 claims analytics on FocalPoint →

BAVENCIO CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

JW / JZ modifiers apply

CMS has identified Bavencio (J9023) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

BAVENCIO Medically Unlikely Edits (MUE)

The most billing units of J9023 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 10 mg.

Practitioner Office & Hospital Outpatient

140 units / day

= 1,400 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

BAVENCIO Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Advanced Renal Cell Carcinoma Locally Advanced or Metastatic Urothelial Carcinoma Metastatic Merkel Cell Carcinoma

Drug Class

AntibodiesMonoclonal [CS]Programmed Death Ligand-1 Antagonists [MoA]Programmed Death Ligand-1 Blocker [EPC]Programmed Death Ligand-1-directed Antibody Interactions [MoA]

Frequently Asked Questions

Is there an available Bavencio billing and coding guide?

Billing and coding information for BAVENCIO can be found through EMD Serono. Visit Here →

Are there any available Bavencio patient assistance programs?

BAVENCIO patient assistance information can be found through EMD Serono. Visit Here →

Where can I find Bavencio prescribing information?

BAVENCIO prescribing information can be found at the link below: Visit Here →

Where can I find Bavencio side effect information?

Information regarding BAVENCIO's side effects can be found at MedlinePlus Visit Here →

Does billing BAVENCIO require JZ/JW wastage modifiers?

CMS has identified BAVENCIO(J9023) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.